Article
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
PFAS Exposure Linked to Increased Risk of Type 2 Diabetes, Study Finds
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
Semaglutide, Tirzepatide Cut Dementia, Stroke Risk in Type 2 Diabetes
How Can Employers Leverage the DPP to Improve Diabetes Rates?
Semaglutide Linked to Lower Dementia Risk in Type 2 Diabetes
Previsit Tools Boost Diabetes Deprescribing in Older Adults, Study Finds